Strides Pharma Science Limited — Tacrolimus Exporter Profile
Indian Pharmaceutical Exporter · #8 for Tacrolimus · $3.5M export value · DGFT Verified
Strides Pharma Science Limited is the #8 Indian exporter of Tacrolimus with $3.5M in export value and 69 verified shipments. Strides Pharma Science Limited holds a 1.7% market share in Tacrolimus exports across 6 countries. The company exports 42 pharmaceutical products worth $179.3M across 20 therapeutic categories.
Strides Pharma Science Limited — Tacrolimus Export Profile: Buyers & Destinations
Where Does Strides Pharma Science Limited Export Tacrolimus?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.9M | 44 | 75.4% |
| AUSTRALIA | $324.5K | 11 | 12.6% |
| SOUTH AFRICA | $125.8K | 7 | 4.9% |
| ETHIOPIA | $95.4K | 4 | 3.7% |
| GEORGIA | $84.4K | 2 | 3.3% |
| AUSTRIA | $4.6K | 1 | 0.2% |
Strides Pharma Science Limited exports Tacrolimus to 6 countries. The largest destination is UNITED STATES accounting for 75.4% of Strides Pharma Science Limited's Tacrolimus shipments, followed by AUSTRALIA (12.6%) and SOUTH AFRICA (4.9%). These destinations reflect Strides Pharma Science Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Tacrolimus from Strides Pharma Science Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| STRIDES PHARMA INC | UNITED STATES | $981.5K | 22 |
| STRIDES PHARMA INC, | UNITED STATES | $853.5K | 19 |
| ARROW PHARMACEUTICALS PTY LTD, | AUSTRALIA | $237.4K | 8 |
| STRIDES SOUTH AFRICA PTY LTD | SOUTH AFRICA | $119.0K | 6 |
| UPS SCS | UNITED STATES | $113.3K | 3 |
| COMMERCIAL BANK OF ETHIOPIA | ETHIOPIA | $95.4K | 4 |
| NUGESHI LTD | GEORGIA | $84.4K | 2 |
| ARROW PHARMACEUTICALS PTY LTD., | AUSTRALIA | $49.5K | 2 |
| ARROW PHARMACEUTICALS PTY LTD | AUSTRALIA | $37.6K | 1 |
| STRIDES SOUTH AFRICA PTY LTD, | SOUTH AFRICA | $6.9K | 1 |
Strides Pharma Science Limited supplies Tacrolimus to 11 buyers globally. The largest buyer is STRIDES PHARMA INC (UNITED STATES), followed by STRIDES PHARMA INC, (UNITED STATES) and ARROW PHARMACEUTICALS PTY LTD, (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Tacrolimus Export Value and How Much Does Strides Pharma Science Limited Contribute?
India exported $92.4M worth of Tacrolimus through 4,611 shipments from 299 suppliers to 127 countries, serving 727 buyers globally. Strides Pharma Science Limited contributes $3.5M to this total, accounting for 1.7% of India's Tacrolimus exports. Strides Pharma Science Limited ships Tacrolimus to 6 countries through 11 buyers.
What Is the Average Shipment Value for Strides Pharma Science Limited's Tacrolimus Exports?
Strides Pharma Science Limited's average Tacrolimus shipment value is $50.0K per consignment, based on 69 shipments totaling $3.5M. The largest destination is UNITED STATES (75.4% of Strides Pharma Science Limited's Tacrolimus exports).
How Does Strides Pharma Science Limited Compare to Other Indian Tacrolimus Exporters?
Strides Pharma Science Limited ranks #8 among 299 Indian Tacrolimus exporters with a 1.7% market share. The top 3 exporters are SANDOZ PRIVATE LIMITED ($36.9M), INTAS PHARMACEUTICALS LIMITED ($22.5M), ALKEM LABORATORIES LIMITED ($8.4M). Strides Pharma Science Limited processed 69 shipments to 6 destination countries.
What Tacrolimus Formulations Does Strides Pharma Science Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| Tacrolimus Capsules USP [5mg] [Hard Gela | $139.1K | 3 |
| TACROLIMUS CAPSULES USP (5MG)(HARD GELAT | $100.0K | 2 |
| Tacrolimus Capsules USP [0.5mg] [Hard Ge | $64.7K | 2 |
| PHARMA : TACROLIMUS CAPSULES USP 0.5MG ( | $62.9K | 3 |
| TACROLIMUS CAPSULES USP 1MG HARD GELATIN 15552 X 100S HDPE | $50.0K | 1 |
| TACROLIMUS CAPSULES USP 0.5MG HARD GELATIN 15840 X 100S HDPE | $50.0K | 1 |
| TACROLIMUS CAPSULES USP 1 MG HARD GELATIN. 39024 X 100S HDPE | $50.0K | 1 |
| TACROLIMUS CAPSULES USP 1 MG HARD GELATIN 11328 X 100S HDPE | $50.0K | 1 |
| Tacrolimus Capsules USP [5mg] [Hard Gelatin 4128.00 X 100'S HDPE | $50.0K | 1 |
| TACROLIMUS CAPSULES USP [5MG] [HARD GELATIN 4,128.00 X 100'S HDPE | $50.0K | 1 |
Strides Pharma Science Limited exports 62 distinct Tacrolimus formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Tacrolimus Capsules USP [5mg] [Hard Gela with 3 shipments worth $139.1K.
Regulatory Requirements: Exporting Tacrolimus to Key Markets
What Strides Pharma Science Limited must comply with to export Tacrolimus to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Strides Pharma Science Limited Compare to Nearest Tacrolimus Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | PANACEA BIOTEC PHARMA LIMITED | $5.2M | 103 | 19 | $50.0K |
| 6 | DR.REDDY'S LABORATORIES LTD | $4.2M | 84 | 4 | $50.0K |
| 8 | STRIDES PHARMA SCIENCE LIMITED ★ | $3.5M | 69 | 6 | $50.0K |
| 12 | GLENMARK PHARMACEUTICALS LIMITED | $2.1M | 58 | 13 | $36.2K |
| 13 | ENCUBE ETHICALS PRIVATE LIMITED | $2.0M | 44 | 1 | $45.1K |
Strides Pharma Science Limited ranks #8 among 299 Indian Tacrolimus exporters. Average shipment value of $50.0K compared to the market average of $309.1K. The closest competitors by value are PANACEA BIOTEC PHARMA LIMITED and DR.REDDY'S LABORATORIES LTD.
Which Indian Ports Ship Tacrolimus Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 741 | 16.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 645 | 14.0% |
| DELHI AIR CARGO ACC (INDEL4) | 398 | 8.6% |
| NHAVA SHEVA SEA (INNSA1) | 358 | 7.8% |
| DELHI AIR | 320 | 6.9% |
| AHEMDABAD AIR ACC (INAMD4) | 175 | 3.8% |
| JNPT/ NHAVA SHEVA SEA | 169 | 3.7% |
| Bombay Air | 141 | 3.1% |
What Other Immunosuppressants Products Does Strides Pharma Science Limited Export?
Strides Pharma Science Limited also exports these immunosuppressants products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Strides Pharma Science Limited's Tacrolimus Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Strides Pharma Science Limited. The Israel-Iran conflict has led to increased tensions in the Red Sea, a critical shipping route. This situation has resulted in higher shipping costs and potential delays, impacting the timely delivery of pharmaceutical products to key markets.
Conversely, ongoing trade tensions between the U.S. and China have opened avenues for Indian pharmaceutical companies. The U.S. is increasingly looking towards India as a reliable supplier of generic drugs, providing companies like Strides with opportunities to expand their footprint in the American market.
In the European Union, the implementation of the Falsified Medicines Directive (FMD) has imposed stringent compliance requirements. Indian exporters must adapt to these regulations to maintain market access. However, the recent India–EU Free Trade Agreement, concluded in January 2026, aims to eliminate tariffs on pharmaceuticals, potentially enhancing the competitiveness of Indian exporters in the European market. (en.wikipedia.org)
Strides Pharma Science Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for pharmaceutical exporters. Strides Pharma Science Limited has demonstrated a commitment to quality, as evidenced by the U.S. FDA's classification of its Chestnut Ridge facility in New York as "Voluntary Action Indicated" following an inspection in December 2025. This classification indicates that while some observations were noted, they are not expected to lead to regulatory action, reflecting the facility's adherence to Good Manufacturing Practices. (economictimes.indiatimes.com)
Such regulatory approvals are crucial for sustaining and expanding market presence, particularly in stringent markets like the U.S. and the EU. Continuous investment in compliance and quality assurance will be essential for Strides to navigate the evolving regulatory landscape effectively.
About Strides Pharma Science Limited
Strides Pharma Science Limited exports 42 products worth $179.3M. Beyond Tacrolimus, top products include Ibuprofen, Rosuvastatin, Gabapentin, Vancomycin, Prednisone. View the complete Strides Pharma Science Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tacrolimus — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Tacrolimus shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Strides Pharma Science Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 69 individual customs records matching Strides Pharma Science Limited exporting Tacrolimus, covering 62 formulations to 6 countries via 11 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 127+ countries, 727+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Tacrolimus Export Data from Strides Pharma Science Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Strides Pharma Science Limited's Tacrolimus exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Strides Pharma Science Limited
Full Company Profile →
42 products · $179.3M total trade · 20 categories
Tacrolimus Stats
Company Overview
Top Products by Strides Pharma Science Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Strides Pharma Science Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tacrolimus. For current shipment-level data, contact TransData Nexus.